Literature DB >> 25302218

Azithromycin-induced rash in a patient of infectious mononucleosis - a case report with review of literature.

Indranil Banerjee1, Somnath Mondal2, Sukanta Sen3, Santanu Kumar Tripathi4, Gautam Banerjee5.   

Abstract

Antibiotic induced skin rash in setting of infectious mononucleosis is often encountered in clinical practice. However, macrolides like azithromycin are considered relatively safe and till date only two cases of azithromycin induced rash in setting of infectious mononucleosis have been reported. The following report illustrates the case of a 23-year-old man suffering from infectious mononucleosis who exhibited a generalized cutaneous rash following treatment with azithromycin. Using the Naranjo ADR probability scale, this case of acute onset rash following azithromycin administration was found to be in 'probable' category. The mechanism of antibiotic-induced rash in patients suffering from infectious mononucleosis is incompletely understood. It has been suggested that the rash could result from virus mediated immunomodulation or due to altered drug metabolism. The report calls for cautious use of antibiotics in the setting of suspected viral infections like infectious mononucleosis as injudicious use might increase the risk of deleterious skin reactions and increase the cost of healthcare.

Entities:  

Keywords:  Azithromycin; Infectious Mononucleosis; Rash

Year:  2014        PMID: 25302218      PMCID: PMC4190740          DOI: 10.7860/JCDR/2014/9865.4729

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

Review 1.  Infectious mononucleosis.

Authors:  Katherine Luzuriaga; John L Sullivan
Journal:  N Engl J Med       Date:  2010-05-27       Impact factor: 91.245

Review 2.  The biology of the immune system.

Authors:  D P Huston
Journal:  JAMA       Date:  1997-12-10       Impact factor: 56.272

3.  Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction.

Authors:  D J Schissel; D Singer; K David-Bajar
Journal:  Cutis       Date:  2000-03

4.  The ampicillin rash. Lymphocyte transformation by ampicillin polymer.

Authors:  A W Webster; R A Thompson
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

5.  Drug rash with ampicillin and other penicillins.

Authors:  S Shapiro; V Siskind; D Slone; G P Lewis; H Jick
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 7.  Cephalexin rash in infectious mononucleosis.

Authors:  G L McCloskey; M C Massa
Journal:  Cutis       Date:  1997-05

8.  Azithromycin-induced rash in infectious mononucleosis.

Authors:  Ghenwa K Dakdouki; Khalil H Obeid; Souha S Kanj
Journal:  Scand J Infect Dis       Date:  2002

9.  An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction.

Authors:  J R Lupton; P Figueroa; P Tamjidi; B J Berberian; V I Sulica
Journal:  Cutis       Date:  1999-08

10.  Incidence of rash after amoxicillin treatment in children with infectious mononucleosis.

Authors:  Aluma Chovel-Sella; Amir Ben Tov; Einat Lahav; Orna Mor; Hagit Rudich; Gideon Paret; Shimon Reif
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

  10 in total
  3 in total

1.  Letter to the editor about Maculopapular Rash after Penicillin Injection in a Patient with Confirmed Infectious Mononucleosis.

Authors:  Mostafa Shahabi Nejad; Shayan Shahabi Nejad; Naser Shahabi Nejad
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 2.  Macrolide Allergic Reactions.

Authors:  Kristy M Shaeer; Elias B Chahine; Sheeba Varghese Gupta; Jonathan C Cho
Journal:  Pharmacy (Basel)       Date:  2019-09-18

3.  Infectious mononucleosis skin rash without previous antibiotic use.

Authors:  Theocharis Koufakis; Ioannis Gabranis
Journal:  Braz J Infect Dis       Date:  2015-06-09       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.